Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances

被引：10
|
作者：
Al Tabosh, Tala [1 ]
Al Tarrass, Mohammad [1 ]
Tourvieilhe, Laura [2 ,3 ]
Guilhem, Alexandre [2 ,3 ,4 ]
Dupuis-Girod, Sophie [1 ,2 ,3 ]
Bailly, Sabine [1 ]
机构：
[1] Grenoble Alpes Univ, Biosante Unit U1292, INSERM, CEA, F-38000 Grenoble, France
[2] Femme Me`re Enfants Hosp, Hosp Civils Lyon, Bron, France
[3] Femme Mere Enfants Hosp, Genet Dept, Bron, France
[4] Burgundy Univ, TAI IT Autoimmun Unit RIGHT UMR1098, INSERM, EFS BFC, Besancon, France
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2024年 / 134卷 / 04期
基金：
欧盟地平线“2020”;
关键词：
CAUSES ARTERIOVENOUS-MALFORMATIONS; TGF-BETA RECEPTOR; ENDOTHELIAL-CELLS; VASCULAR MALFORMATIONS; MOUSE MODEL; BEVACIZUMAB; EPISTAXIS; ENDOGLIN; ALK1; THALIDOMIDE;
D O I：
10.1172/JCI176379
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Hereditary hemorrhagic telangiectsia (HHT) is an inherited vascular disorder with highly variable expressivity, affecting up to 1 in 5,000 individuals. This disease is characterized by small arteriovenous malformations (AVMs) in mucocutaneous areas (telangiectases) and larger visceral AVMs in the lungs, liver, and brain. HHT is caused by loss-of-function mutations in the BMP9-10/ENG/ALK1/SMAD4 signaling pathway. This Review presents up-to-date insights on this mutated signaling pathway and its crosstalk with proangiogenic pathways, in particular the VEGF pathway, that has allowed the repurposing of new drugs for HHT treatment. However, despite the substantial benefits of these new treatments in terms of alleviating symptom severity, this not-so-uncommon bleeding disorder still currently lacks any FDA- or European Medicines Agency-approved (EMA-approved) therapies.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
    Ardelean, Daniela S.
    Letarte, Michelle
    FRONTIERS IN GENETICS, 2015, 6
  • [32] THERAPEUTIC EMBOLIZATION FOR CONTROL OF EPISTAXIS IN A PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
    WEISSMAN, JL
    JUNGREIS, CA
    JOHNSON, JT
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1995, 16 (02) : 138 - 140
  • [33] Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges
    Tual-Chalot, Simon
    Oh, S. Paul
    Arthur, Helen M.
    FRONTIERS IN GENETICS, 2015, 6
  • [34] Choroidal telangiectasia in a patient with hereditary hemorrhagic telangiectasia
    D-C Tsai
    A-G Wang
    A-F Lee
    W-M Hsu
    J-H Liu
    M-Y Yen
    Eye, 2002, 16 : 92 - 94
  • [35] Choroidal telangiectasia in a patient with hereditary hemorrhagic telangiectasia
    Tsai, DC
    Wang, AG
    Lee, AF
    Hsu, WM
    Liu, JH
    Yen, MY
    EYE, 2002, 16 (01) : 92 - 94
  • [36] Hereditary hemorrhagic telangiectasia - Reply
    Guttmacher, AE
    Marchuk, DA
    White, RI
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05): : 331 - 332
  • [37] Imaging of hereditary hemorrhagic telangiectasia
    Jaskolka, J
    Wu, L
    Chan, RP
    Faughnan, ME
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (02) : 307 - 314
  • [38] AMINOACIDURIA IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
    CITRON, BP
    PINCUS, IJ
    HALPERN, M
    WARE, A
    HAVERBAC.BJ
    GASTROENTEROLOGY, 1968, 54 (06) : 1226 - &
  • [39] ANGIOGRAPHY IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
    NYMAN, U
    ACTA RADIOLOGICA-DIAGNOSIS, 1977, 18 (05): : 581 - +
  • [40] Schizencephaly in Hereditary Hemorrhagic Telangiectasia
    Gaines, J. J.
    Gilbert, B. C.
    Gossage, J. R.
    Parker, W.
    Reddy, A.
    Forseen, S. E.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, 43 (11) : 1603 - 1607
12345